Topics:
Head and Neck Cancers • Radiation Oncology
Should chemoradiotherapy to primary and neck be offered to patients with Stage IVC nasopharyngeal carcinoma with limited osseous disease?
What are the data for loco-regional and distant recurrence rates with and without local therapy? What is the OS advantage?
Answer from: Radiation Oncologist at Community Practice
Yes. Please refer to the recent small phase III randomized trial: You et al., PMID 32701129. Anecdotally, I have treated an Asian patient with EBV-associated NPC who had a single sternal met at presentation with definitive chemoxrt (no induction) who is is ~7 years post treatment and is NED.&nb...
Sign in or Register to read more